WORK Medical Technology Group LTD Holds Annual Shareholder Meeting

TL;DR

WORK Medical Tech held its shareholder meeting Feb 7, 2025. No details on outcomes yet.

AI Summary

WORK Medical Technology Group LTD held its Annual General Meeting of Shareholders on February 7, 2025. The company, incorporated in China, is involved in the surgical and medical instruments industry. The filing does not disclose specific resolutions or outcomes from the meeting, only that it took place.

Why It Matters

This filing confirms the routine annual meeting of shareholders for WORK Medical Technology Group LTD, a necessary corporate governance event for publicly traded companies.

Risk Assessment

Risk Level: low — This is a routine corporate filing confirming a shareholder meeting, with no new financial or operational information provided.

Key Players & Entities

• WORK Medical Technology Group LTD (company) — Filer of the report
• February 7, 2025 (date) — Date of the Annual General Meeting of Shareholders
• 001-42256 (company) — Commission File Number
• 3841 (industry_code) — Standard Industrial Classification for Surgical & Medical Instruments & Apparatus

FAQ

Filing Documents

• ea0230188-6k_workmedi.htm (6-K) — 22KB
• 0001213900-25-011316.txt ( ) — 24KB

From the Filing

OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2025 Commission File Number: 001-42256 WORK Medical Technology Group LTD Floor 23, No. 2 Tonghuinan Road Xiaoshan District, Hangzhou City, Zhejiang Province The People’s Republic of China (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F Results of WORK Medical Technology Group LTD’s Annual General Meeting of Shareholders The Annual General Meeting of Shareholders (the “Meeting”) of WORK Medical Technology Group LTD (the “Company”) was held at Floor 23, No. 2 Tonghuinan Road, Xiaoshan District, Hangzhou City, Zhejiang Province, China, on February 5, 2025, at 9:30 a.m. EST, with the ability given to the shareholders to join virtually via live audio webcast at http://www.virtualshareholdermeeting.com/WOK2025. At the close of business on January 7, 2025, the record date for the determination of holders of the ordinary shares of the Company (the “Ordinary Shares”) entitled to vote at the Meeting, there were a total of 14,591,942 issued and outstanding Ordinary Shares, each being entitled to one (1) vote. At the Meeting, the holders of 8,572,632 Ordinary Shares of the Company were represented in person or by proxy, constituting a quorum. At the Meeting, the shareholders of the Company adopted the following resolutions : 1. An ordinary resolution to approve the re-election of Dr. Xiaoyang Li as a director of the Company (“Proposal No. 1); 2. An ordinary resolution to approve the re-election of Mr. Robert Brian Johnson as a director of the Company (“Proposal No. 2”); 3. An ordinary resolution to approve the re-election of Mr. Baiming Yu as a director of the Company (“Proposal No. 3”); 4. An ordinary resolution to approve the re-election of Mr. Shuang Wu as a director of the Company (“Proposal No. 4”); 5. An ordinary resolution to approve the re-election of Mr. Zhenguo Wu as a director of the Company (“Proposal No. 5”); 6. An ordinary resolution to approve the increase of the Company’s authorized share capital (“Proposal No. 6”); 7. An ordinary resolution to approve the re-designation and re-classification of the Company’s authorized share capital (“Proposal No. 7”); and 8. A special resolution to adopt an Amended and Restated Memorandum and Articles of Association of the Company (“Proposal No. 8”). The results of the vote at the Meeting for the resolutions were as follows: *Proposal For Against Abstain No. 1 8,572,632 0 0 No. 2 8,572,632 0 0 No. 3 8,572,620 0 12 No. 4 8,572,632 0 0 No. 5 8,572,632 0 0 No. 6 8,572,603 1 28 No. 7 8,572,615 1 16 No. 8 8,572,629 1 2 * The numbers in this column correspond to those in the third paragraph of this report. 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Dated: February 7, 2025 WORK Medical Technology Group LTD By: /s/ Shuang Wu Name: Shuang Wu Title: Chief Executive Officer and Chairman of the Board of Directors 2

View Full Filing

View this 6-K filing on SEC EDGAR